Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1968-10-7
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0001-9496
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
69-72
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:4876157-Animals,
pubmed-meshheading:4876157-Drug Resistance, Microbial,
pubmed-meshheading:4876157-Escherichia coli,
pubmed-meshheading:4876157-Escherichia coli Infections,
pubmed-meshheading:4876157-Mice,
pubmed-meshheading:4876157-Nalidixic Acid,
pubmed-meshheading:4876157-Pyelonephritis
|
pubmed:year |
1968
|
pubmed:articleTitle |
[Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis].
|
pubmed:publicationType |
Journal Article
|